Johann Matthias Graf von der Schulenburg
Names
| first: |
Johann |
| middle: |
Matthias |
| last: |
Graf von der Schulenburg |
Identifer
Contact
| phone: |
+491633988889 |
| postal address: |
Schleiermacherstrasse 24
30625 Hannover
Germany |
Affiliations
-
Leibniz Universität Hannover
/ Wirtschaftswissenschaftliche Fakultät
Research profile
author of:
- Voting on Social Security: The Family as Decision‐Making Unit (RePEc:bla:kyklos:v:40:y:1987:i:4:p:529-547)
by Friedrich Breyer & J.‐Matthias Graf V. D. Schulenburg** - Entwicklung der Leistungsempfängerzahlen in der Gesetzlichen Pflegeversicherung - Zum Einfluss unterschiedlicher Morbiditätsannahmen auf die Entwicklung der sozialrechtlich anerkannten Pflegebedürftig (RePEc:dah:aeqsjb:v134_y2014_i2_q2_p209-236)
by David Bowles & Andy Zuchandke & Wolfgang Greiner & J.-Matthias Graf von der Schulenburg - Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study (RePEc:eee:hepoli:v:108:y:2012:i:1:p:19-26)
by Linertová, Renata & Serrano-Aguilar, Pedro & Posada-de-la-Paz, Manuel & Hens-Pérez, Manuel & Kanavos, Panos & Taruscio, Domenica & Schieppati, Arrigo & Stefanov, Rumen & Péntek, Márta & Delgado, Claud - Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments (RePEc:eee:hepoli:v:126:y:2022:i:1:p:49-59)
by Dabbous, Monique & Toumi, Mondher & Simoens, Steven & Wasem, Juergen & Saal, Gauri & Wang, Yitong & Osuna, José Luis Huerta & François, Clément & Annemans, Lieven & Graf von der Schulenburg, Johann-Ma - Diffusion of innovations: treatment of Alzheimer's disease in Germany (RePEc:eee:hepoli:v:60:y:2002:i:1:p:59-66)
by Ruof, Jorg & Mittendorf, Thomas & Pirk, Olaf & Graf von der Schulenburg, J. -Matthias - Cost of poor adherence to anti-hypertensive therapy in five European countries (RePEc:hal:journl:hal-01616348)
by F.S. Mennini & A. Marcellusi & J.M. Graf von Der Schulenburg & A. Gray & Pierre Lévy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. E. Schmieder - Grundlagen und Methoden von GKV-Routinedatenstudien (RePEc:han:dpaper:dp-534)
by Neubauer, Sarah & Zeidler, Jan & Lange, Ansgar & Graf von der Schulenburg, J.-Matthias - Nach welchen ökonomischen Methoden sollten Gesundheitsleistungen in Deutschland evaluiert werden? / According to Which Economic Methods Should Health Care Services Become Evaluated in Germany? (RePEc:jns:jbstat:v:227:y:2007:i:5-6:p:787-805)
by Schulenburg J.-Matthias Graf von der & Vauth Christoph - Reliability of Risk Management: Market Insurance, Self-Insurance and Self-Protection Reconsidered (RePEc:pal:genrir:v:16:y:1991:i:1:p:45-58)
by Eric Briys & Harris Schlesinger & J.-Matthias Graf v. d. Schulenburg - Reinsurance Brokers and Advice Quality: Is There a Need for Regulation? (RePEc:pal:genrir:v:34:y:2009:i:1:p:20-46)
by Michael Sonnenholzner & Sebastian Friese & J.-Matthias Graf v. d. Schulenburg - Corporate Management of Highly Dynamic Risks: Evidence from the Demand for Terrorism Insurance in Germany (RePEc:pal:genrir:v:37:y:2012:i:1:p:57-82)
by Christian Thomann & Razvan Pascalau & J.-Matthias Graf von der Schulenburg - On the Impact of the Financial Crisis on the Dividend Policy of the European Insurance Industry (RePEc:pal:gpprii:v:35:y:2010:i:1:p:53-62)
by Sebastian Reddemann & Tobias Basse & Johann-Matthias Graf von der Schulenburg - Impact of the Introduction of the Social Long-Term Care Insurance in Germany on Financial Security Assessment in Case of Long-Term Care Need* (RePEc:pal:gpprii:v:35:y:2010:i:4:p:626-643)
by Andy Zuchandke & Sebastian Reddemann & Simone Krummaker & J.-Matthias Graf von der Schulenburg - An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies (RePEc:pal:gpprii:v:42:y:2017:i:4:d:10.1057_s41288-017-0069-9)
by Dirk Wrede & Annemarie Will & Tim Linderkamp & Johann-Matthias Graf Schulenburg - Correction to: An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies (RePEc:pal:gpprii:v:44:y:2019:i:2:d:10.1057_s41288-018-00118-2)
by Dirk Wrede & Annemarie Will & Tim Linderkamp & Johann-Matthias Graf Schulenburg - Affirmative and silent cyber coverage in traditional insurance policies: Qualitative content analysis of selected insurance products from the German insurance market (RePEc:pal:gpprii:v:45:y:2020:i:4:d:10.1057_s41288-020-00183-6)
by Dirk Wrede & Tino Stegen & Johann-Matthias Schulenburg - Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe (RePEc:rtv:ceisrp:299)
by Francesco Saverio Mennini & Andrea Marcellusi & J.Matthias Graf von der Schulenburg & Alastair Gray & Pierre L. Levy & Paolo Sciattella & Marco Soro & Gianandrea Staffiero & Jan Zeidler & Aldo Maggion - Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany (RePEc:spr:aphecp:v:14:y:2016:i:4:d:10.1007_s40258-016-0239-0)
by I. Aumann & M. Treskova & N. Hagemann & J.-M. Schulenburg - Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer (RePEc:spr:eujhec:v:10:y:2010:i:1:p:21-26)
by J.-Matthias Schulenburg & Anne Prenzler & Willemien Schurer - EJHE has an official impact factor of 1.337 (RePEc:spr:eujhec:v:11:y:2010:i:5:p:435-435)
by J.-Matthias Graf von der Schulenburg - Letter from the editors (RePEc:spr:eujhec:v:12:y:2011:i:1:p:1-1)
by J.-Matthias Graf von der Schulenburg & Wolfgang Greiner - Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems (RePEc:spr:eujhec:v:16:y:2015:i:2:p:113-118)
by J.-Matthias Schulenburg & Martin Frank - Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe (RePEc:spr:eujhec:v:17:y:2016:i:1:d:10.1007_s10198-016-0786-1)
by A. Kuhlmann & T. Schmidt & M. Treskova & J. López-Bastida & R. Linertová & J. Oliva-Moreno & P. Serrano-Aguilar & M. Posada-de-la-Paz & P. Kanavos & D. Taruscio & A. Schieppati & G. Iskrov & M. Péntek - HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies (RePEc:spr:eujhec:v:21:y:2020:i:9:d:10.1007_s10198-020-01212-w)
by Doug Coyle & Isabelle Durand-Zaleski & Jasmine Farrington & Louis Garrison & Johann-Matthias Graf von der Schulenburg & Wolfgang Greiner & Louise Longworth & Aurélie Meunier & Anne-Sophie Moutié & Ste - COVID-19: not the time for health economists? A plea for more proactive health economic involvement (RePEc:spr:eujhec:v:22:y:2021:i:7:d:10.1007_s10198-021-01349-2)
by J.-Matthias Graf von der Schulenburg - Commentary (RePEc:spr:eujhec:v:3:y:2002:i:2:p:138-138)
by J.-Matthias Graf Schulenburg - Validating the EQ-5D with time trade off for the German population (RePEc:spr:eujhec:v:6:y:2005:i:2:p:124-130)
by W. Greiner & C. Claes & J. J. V. Busschbach & J.-M. Schulenburg - German health care system in transition (RePEc:spr:eujhec:v:6:y:2005:i:2:p:183-187)
by J.-Matthias Schulenburg - Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany (RePEc:spr:eujhec:v:6:y:2005:i:4:p:317-321)
by Werner Kulp & J.-M. Schulenburg & Wolfgang Greiner - Editor’s note (RePEc:spr:eujhec:v:8:y:2007:i:3:p:179-179)
by J.-Matthias Graf von der Schulenburg & Wolfgang Greiner - Health Economics Review (RePEc:spr:hecrev)
from Springer as editor - Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers (RePEc:spr:hecrev:v:1:y:2011:i:1:p:1-10:10.1186/2191-1991-1-6)
by Jan-Marc Hodek & J-Matthias von der Schulenburg & Thomas Mittendorf - Greetings from the Editors (RePEc:spr:hecrev:v:1:y:2011:i:1:p:1-2:10.1186/2191-1991-1-9)
by J-Matthias Graf von der Schulenburg & Sebastian Braun - Promoting vaccinations - an analysis of measures taken by German statutory health insurers (RePEc:spr:hecrev:v:1:y:2011:i:1:p:1-6:10.1186/2191-1991-1-16)
by Kathrin Damm & Jana Schubert & J-Matthias von der Schulenburg - Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany (RePEc:spr:hecrev:v:2:y:2012:i:1:p:1-13:10.1186/2191-1991-2-4)
by Alexander Kuhlmann & Ulrike Theidel & Mathias Pletz & J-Matthias von der Schulenburg - Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system (RePEc:spr:hecrev:v:3:y:2013:i:1:p:1-17:10.1186/2191-1991-3-9)
by Alexander Kuhlmann & Anne Prenzler & Jan Hacker & J-Matthias Graf von der Schulenburg - Regional differences in health care of patients with inflammatory bowel disease in Germany (RePEc:spr:hecrev:v:5:y:2015:i:1:p:1-11:10.1186/s13561-015-0067-1)
by Ansgar Lange & Anne Prenzler & Oliver Bachmann & Roland Linder & Sarah Neubauer & Jan Zeidler & Michael Manns & J.-Matthias von der Schulenburg - Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis - (RePEc:spr:hecrev:v:5:y:2015:i:1:p:1-9:10.1186/s13561-015-0078-y)
by Mike Klora & Jan Zeidler & Roland Linder & Frank Verheyen & J.-Matthias von der Schulenburg - Benefit assessment in Germany: implications for price discounts (RePEc:spr:hecrev:v:6:y:2016:i:1:d:10.1186_s13561-016-0109-3)
by Ulrike Theidel & J-Matthias Graf von der Schulenburg - Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks (RePEc:spr:hecrev:v:6:y:2016:i:1:d:10.1186_s13561-016-0130-6)
by Katharina Schmidt & Ana Babac & Frédéric Pauer & Kathrin Damm & J-Matthias von der Schulenburg - “Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations (RePEc:spr:hecrev:v:8:y:2018:i:1:d:10.1186_s13561-018-0209-3)
by Thomas R. Staab & Miriam Walter & Sonja Mariotti Nesurini & Charalabos-Markos Dintsios & J.-Matthias Graf von der Schulenburg & Volker E. Amelung & Jörg Ruof - Operations Research Proceedings 2012 (RePEc:spr:oprepr:978-3-319-00795-3)
by None - German Value Set for the EQ-5D-5L (RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8)
by Kristina Ludwig & J.-Matthias Graf von der Schulenburg & Wolfgang Greiner - Bonus options in health insurance by Peter Zweifel. Awer Academic Publishers, Dordrecht, 1992. No. of ges: xii + 141. ISBN 0‐7923‐1722‐X (RePEc:wly:hlthec:v:2:y:1993:i:1:p:81-82)
by J.‐Matthias Graf v. d. Schulenburg - Digital Transformation in Back-Offices of German Insurance Companies (RePEc:wsi:ijitmx:v:20:y:2023:i:08:n:s0219877023500505)
by Christoph Schwarzbach & Theresa Eden & Oliver Werth & Ute Lohse & Michael H. Breitner & Johann-Matthias Graf von der Schulenburg